Welcome to our dedicated page for Emerson Elec Co news (Ticker: EMR), a resource for investors and traders seeking the latest updates and insights on Emerson Elec Co stock.
Emerson Electric Co. (NYSE: EMR) regularly issues news and updates that reflect its role as a global automation and industrial technology company. The company’s press releases describe a focus on advanced automation, industrial software and intelligent devices that support what Emerson calls the autonomous future. News items often highlight how its technologies are applied in mission‑critical and essential industries.
Recent announcements include earnings releases and outlook updates, where Emerson discusses segment performance, cash flow, capital allocation and guidance. These communications are typically accompanied by information about investor conference calls and webcasts, giving context for how management views the company’s progress and financial framework.
Emerson’s news flow also covers strategic and technology developments. Examples from its own releases include recognition as an "Industrial IoT Company of the Year" and the introduction of AI‑enabled software such as Guardian Virtual Advisor, which the company describes as supporting lifecycle management and industrial resilience. Project‑specific news has described automation engagements for mining and critical minerals projects, where Emerson’s automation portfolio and services are presented as supporting safety, efficiency and environmental performance.
Investors and observers following EMR news can expect updates on segment reporting changes, portfolio developments such as acquisitions and divestitures, automation and software launches, awards and recognitions, and details of investor events. The EMR news page on Stock Titan aggregates these company communications so readers can review how Emerson presents its strategy, segment structure, technology focus and capital allocation over time.
Emerson (NYSE: EMR) has successfully completed the acquisition of all remaining outstanding shares of AspenTech not previously owned, marking a significant milestone in Emerson's portfolio transformation. The tender offer expired on March 11, 2025, with shareholders receiving $265.00 per share in cash.
The tender offer resulted in approximately 19.5 million shares being validly tendered, representing about 72% of AspenTech's outstanding shares not already owned by Emerson. Following the tender offer completion, AspenTech has become a wholly owned subsidiary of Emerson and its shares have ceased trading on NASDAQ.
Key leadership changes include Antonio Pietri's retirement as AspenTech CEO, with Vincent M. Servello appointed as President of the AspenTech business unit. AspenTech will operate as an independent business unit, with its results being consolidated into Emerson's Control Systems & Software segment.
Emerson (NYSE: EMR) has extended its tender offer deadline to acquire remaining Aspen Technology (NASDAQ: AZPN) shares to March 11, 2025, at 5:00 p.m. Eastern Time. The extension accommodates the settlement and tendering of shares due to AspenTech's removal from the S&P MidCap 400 index, effective March 11, 2025.
The tender offer maintains its $265 per share price, which Emerson has stated is its best and final offer. As of March 7, 2025, approximately 6,715,211 shares had been validly tendered and not withdrawn. Previously tendered shares require no additional action from holders.
Emerson (NYSE: EMR) and Zitara Technologies have announced a strategic partnership to enhance battery management solutions. The collaboration will integrate Zitara's advanced battery energy storage systems software into Emerson's Ovation™ automation platform, offering improved battery performance and monitoring capabilities.
The integration aims to provide enhanced energy storage management, optimized battery usage, and improved battery lifetime and safety across various applications. The partnership builds on Emerson's existing investment in Zitara through Emerson Ventures and will help utilities meet increasing demands for reliable, affordable, and sustainable power and water.
The enhanced Ovation platform will help power operators manage distributed energy resources using real-time data for improved load and demand management, while incorporating Zitara's advanced battery monitoring and controls solutions.
Elliott Investment Management, managing funds with over $1.5 billion investment in Aspen Technology (NASDAQ: AZPN), has issued a statement criticizing Emerson Electric's tender offer for remaining AspenTech shares. Elliott strongly opposes the acquisition attempt, characterizing it as a conflicted and deeply flawed process that resembles an opportunistic minority squeeze-out.
The investment firm argues that Emerson's public statements and actions leading to the tender offer demonstrate coercive intent toward minority stockholders. Elliott has declared the transaction unfair and plans to pursue all appropriate remedies against Emerson.
Emerson (NYSE: EMR) has responded to Elliott Investment Management's statement regarding its tender offer to acquire all outstanding shares of AspenTech (NASDAQ: AZPN) not already owned by Emerson. The offer stands at $265 per share in cash, representing Emerson's best and final price following three months of negotiations with AspenTech's Special Committee.
The offer, set to expire on March 10, 2025, requires a majority of minority shares to be tendered for completion. The AspenTech Special Committee, comprising three independent directors, unanimously recommends the transaction as superior to AspenTech's standalone prospects. If the tender offer expires without meeting the majority condition, Emerson will maintain its existing majority ownership stake in AspenTech, which would remain a publicly-traded controlled company.
Elliott Investment Management, managing funds with over $1.5 billion investment in Aspen Technology (NASDAQ: AZPN), has publicly opposed the recently announced tender offer by Emerson Electric Co. (NYSE: EMR). Emerson, AspenTech's majority stockholder, proposed to acquire the remaining shares it doesn't own at $265.00 per share.
As AspenTech's largest minority investor, Elliott stated that Emerson's offer is highly opportunistic and substantially undervalues the company. The investment firm has declared it will not tender its shares at the current price.
Emerson (NYSE: EMR) reported strong Q1 2025 results with net sales reaching $4,175 million, up 1% from the previous year. The company demonstrated significant improvements in profitability, with pretax earnings margin expanding to 18.6% from 4.2% year-over-year. Adjusted earnings per share increased 13% to $1.38, while operating cash flow grew 75% to $777 million.
The company updated its fiscal 2025 outlook, projecting net sales growth of 1.5-3.5% and underlying sales growth of 3-5%. Emerson plans to return approximately $3.2 billion to shareholders through $2.0 billion in share repurchases and $1.2 billion in dividend payments. The company declared a quarterly dividend of $0.5275 per share, payable March 10, 2025.
Emerson (NYSE: EMR) has announced an agreement to acquire the remaining shares of AspenTech (NASDAQ: AZPN) for $265.00 per share in an all-cash tender offer. The transaction values the minority stake at $7.2 billion, with a total company valuation of $17.0 billion in market capitalization and $16.8 billion in enterprise value.
Emerson currently owns approximately 57% of AspenTech following its majority investment in 2022. The transaction, unanimously approved by both companies' boards and recommended by AspenTech's Special Committee, will make AspenTech a wholly owned subsidiary of Emerson. The deal is expected to close in the first half of 2025, subject to customary conditions, including a non-waivable requirement that majority of minority stockholders tender their shares.
Upon completion, AspenTech will cease trading on NASDAQ. Emerson plans to finance the acquisition through cash on hand and debt financing.
Emerson (NYSE: EMR) has announced its schedule for first quarter 2025 earnings release and conference call. The company will release its Q1 2025 results before market open on Wednesday, February 5, 2025. Senior management will host an investor conference call at 8:30 a.m. Eastern Time (7:30 a.m. Central Time) on the same day.
Interested parties can access the live conference call and presentation slides through Emerson's website in the Investors section at www.Emerson.com/investors after completing a registration form. The conference call replay will remain available on the website for three months after the webcast.
Emerson (NYSE: EMR) has been awarded the 'Industrial IoT Innovation of the Year' at the 9th annual IoT Breakthrough Awards for its DeltaV™ Workflow Management software. This next-generation, cloud-based solution helps life sciences companies digitize drug recipe workflows, replacing paper-based records with digital ones.
The software is specifically designed for early-stage development companies with IT infrastructure, requiring no coding experience. It enables simple recipe authoring, execution, and electronic data capture, while generating searchable, exportable digital records. This digital transformation helps minimize contamination risks in sterile clean rooms and accelerates therapy commercialization.
The 2025 IoT Breakthrough Awards program received over 3,850 global nominations. Notably, Emerson has maintained a consistent presence in these awards since 2018, providing automation technologies to the top 25 life sciences companies worldwide. The recognition highlights Emerson's contribution to helping life sciences companies scale and deliver drugs to market safely and efficiently.